Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 6/20 | 0.39 |
| ▸ | SLC9A3 | P48764 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | HRH1 | P35367 | 2/20 | 0.33 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.33 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10855552 | 0.99 | PTGS2 (0.38) | PTGS2SLC9A3KCNH2HTR2AHRH1 | |
| SCHEMBL11019998 | 0.82 | HTR2A (0.35) | HTR2AHRH1 | |
| SCHEMBL11022069 | 0.81 | SMN1; SMN2 (0.43) | KCNH2HTR2AHRH1 | |
| SCHEMBL11018524 | 0.81 | HTR2A (0.44) | KCNH2HTR2AHRH1 | |
| SCHEMBL11018166 | 0.81 | HTR2A (0.48) | HTR2A | |
| Hydrochloric Acid SCHEMBL10857036 | 0.81 | KCNH2 (0.44) | KCNH2HTR2AHRH1 | |
| Hydrochloric Acid SCHEMBL10857042 | 0.81 | KCNH2 (0.44) | KCNH2HTR2AHRH1 | |
| Hydrochloric Acid SCHEMBL10853181 | 0.81 | HTR2A (0.34) | KCNH2HTR2AHRH1 | |
| Hydrochloric Acid SCHEMBL10855338 | 0.80 | SRD5A2 (0.38) | KCNH2HTR2AHRH1 | |
| Hydrochloric Acid SCHEMBL10854594 | 0.79 | HTR2A (0.49) | HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0139296-A2 | Dihydroisoquinoline derivatives | BEECHAM GROUP PLC (GB) | 1985-05-02 | — | — | EP | claimed |